Navigation Links
Colgate To Develop Anti-Cancer Toothpastes And Mouthwashes

AUSTIN, Texas - Oral care product leader Colgate-Palmolive Company has entered into an alliance with Introgen Therapeutics to market oral health care formulations specifically designed to fight against pre-cancerous //conditions in the oral cavity as well as oral cancer.

Towards this end Colgate purchased $20 million of Introgen shares with exclusive rights over the products that are produced by Introgen. Introgen has a wide range of molecular therapeutics that include tumor suppressors such as p53, mda-7, and FUS1. The company is in an advanced stage of developing INGN 234, a mouthwash designed to deliver the p53 tumor suppressor for the prevention of a pre-cancerous condition called Leukoplakia as well as oral cancer. David G. Nance, Chief Executive Officer of Introgen was understandably pleased with the lucrative agreement.

We believe that repair of damaged cells and safe elimination of malignant or pre-malignant cells from the mouth could represent important therapies for dentists, oral health professionals and oncology specialists to prevent and treat oral diseases, he said.

Oral cancer is fast emerging as one of the leading cancers n the world thanks to the killer called Tobacco. Smoking and other factors like chronic trauma do play a large part, but tobacco remains the number 1 culprit. Molecular therapies are emerging technologies that have the potential to fight cancers on the molecular level, giving the patient a better chance of survival and sparing the trauma of chemotherapy as well as radiation therapy. This is the first time that an attempt has been made to deliver a therapeutic agent against oral cancer
'"/>




Page: 1

Related medicine news :

1. Developmental, neurologic problems common in extremely preterm infants
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Risk Of Developing Arthritis
4. Developing HIV fighter
5. Missing Protein In Cancer Development
6. Tomatoes Might Inhibit the Development Of Prostate Cancer
7. Antibiotics Found To Increase The Risk Of Developing Breast Cancer
8. The Effectiveness Of Cancer Drug In Women At Risk Of Developing Cancer
9. Men Who at Risk Of Developing Prostate Cancer
10. Identifying The Risks Of Developing Schizophrenia
11. Patients With Severe Hemophilia At Risk Of Developing Osteoporosis

Post Your Comments:
(Date:11/30/2009)...PRNewswire/ -- Menopause - it,s an unavoidable par...f uncomfortable symptoms that negatively impact qu...s, weight gain , night sweats and lethargy are ju... and perimenopause. What,s worse, menopause signs... actual menopause occurs (perimenopause), and can ...
(Date:11/30/2009)...Uses Tent To Simulate High Altitude, Low O2 Condit...wire/ -- Distance runners who live at high altitud...ir performance during races in areas that are at s... from fatigue, improve their exercise performance ...? ,, That is the question being studied among 1...
(Date:11/30/2009)...PRNewswire/ -- The launch of Invivo Corporation,s ...rst FDA-cleared, fully-automated morphological sys...t of suspicious breast lesions. The ONCAD system w...iety of North America 2009 Annual Meeting in Chica...perts in breast MRI, ONCAD for DynaCAD uses a pate...
(Date:11/30/2009)...results in animals , , MONDAY, Nov. 30...ggest that stem cells from transplanted human-deri...g and heart disorders. , Scientists already kn...ong list of different kinds of cells in the labora...ter in Seoul, Korea, co-author of one of the studi...
(Date:11/30/2009)...ire/ --- Salon Leau announced today they are hosti... raise funds and create positive impact in the fig...ds from each haircut and or color will be donated ...alon Leau has been serving the posh Washington DC ...widely recognized for her innovation in color, cut...
Breaking Medicine News(10 mins):Health News:Anti-Aging Institute of California Offers New Natural Solution for Menopause Symptoms 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 3Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 4Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 2Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 3Health News:Georgetown Hair Salon Helps St. Jude Find A Cure 2
... Insurance Coverage Exclusions for,Pre-existing Co..., WASHINGTON, Oct. 26 The National Patient,Advoc...ganization dedicated,to the mission of creating av...(D-WV) for acting to protect Americans at,risk of ...
...iental,Bioengineering, Inc. (NYSE: AOB ), a leadi...rmaceutical and nutraceutical products in China, t...l investor conferences in,November. The Company w...nagement is currently scheduled to present at,1:55...
...d Companies Control Health Care Costs, DALLAS, Oc...cs" Kenneth H. Cooper, M.D., M.P.H., Cooper Aerobi...r acquisition in the company,s 37-year,history. Co...Benefits merges traditional employee benefits cons...
...n Jack Group, Inc.,(MattsonJack) announces the rel... Database(TM) is designed to help clients make str...g of the importance of mutually,exclusive and over...nd Comorbidity Database(TM) -- Med 2.0, which feat...
...Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the...nced that data from a 12-month study of DAYTRANATM...on Deficit Hyperactivity Disorder (ADHD) patch, de...esented today at a major scientific and educationa...
...ty is a societal problem that needs to be solved. ...patitis or NASH, is just one of the many complicat...or NASH are limited, and therefore there is an unm...ing hand to potentially aid in abolishing the occu...
Other Medicine News:Health News:National Patient Advocate Foundation Hails Senator Rockefeller for Introducing Bill Protecting Patient Access to Health Coverage 2Health News:American Oriental Bioengineering Announces Participation in November Healthcare Conferences 2Health News:An Industry First: New Cooper Health Company Makes Group Employee Benefits Consulting and Wellness Program Design a Package Deal 2Health News:An Industry First: New Cooper Health Company Makes Group Employee Benefits Consulting and Wellness Program Design a Package Deal 3Health News:An Industry First: New Cooper Health Company Makes Group Employee Benefits Consulting and Wellness Program Design a Package Deal 4Health News:The Mattson Jack Group, Inc. Announces the Release of the New Comorbidity Database(TM) 2Health News:Long-term 12-month safety data on ADHD patch DAYTRANA 2Health News:Attenuation of NASH by stimulation of free fatty acid metabolism 2
(Date:11/30/2009)...PRNewswire-FirstCall/ -- NightHawk Radiology Servi...o radiology groups and hospitals throughout the Un...Assurance (QA) program to foster better communicat... and to deliver superior patient care. ,, Nig... program in several presentations at RSNA 2009. Ni...
(Date:11/30/2009)...re/ -- Reportlinker.com announces that a new marke..., Surgical Incision Closures - Global Trends ...al-Incision-Closures---Global-Trends.html ,, S...gnificance, due to the millions of surgical proced...es such as cardiology, obstetrics/gynecology, orth...
(Date:11/30/2009)...RNewswire/ -- Cytokine PharmaSciences, Inc. today ...I-2364, its orally active, small-molecule inhibito...lammatory cytokines. Results of the safety and to...eers confirm the safety of this compound in initia...ts completed the study, including those receiving ...
Breaking Medicine Technology:NightHawk Radiology Launches Redesigned Quality Assurance Program 2Reportlinker Adds Surgical Incision Closures - Global Trends 2Reportlinker Adds Surgical Incision Closures - Global Trends 3Reportlinker Adds Surgical Incision Closures - Global Trends 4Reportlinker Adds Surgical Incision Closures - Global Trends 5Reportlinker Adds Surgical Incision Closures - Global Trends 6Reportlinker Adds Surgical Incision Closures - Global Trends 7Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2Young leukemia and lymphoma patients live longer today than in years past 55090 1Young leukemia and lymphoma patients live longer today than in years past 55090 2The Eli and Edythe Broad Foundation recommit to gastroenterologys future 55086 1The Eli and Edythe Broad Foundation recommit to gastroenterologys future 55086 2U M researchers discover therapeutic target that could help patients with pulmonary fibrosis 55083 1U M researchers discover therapeutic target that could help patients with pulmonary fibrosis 55083 2
...l 2 Novo Nordisk today announced that the Endocri...the United States Food and Drug Administration (FD...ted to liraglutide, a once-daily human GLP-1 analo...ns related to the risk profile of liraglutide. , ...bers supported that appropriate evidence of cardio...
...2 Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Co...e discovery and development of novel antibiotics f...s, today announced that its lead compound, delaflo...tors for the 8th annual report on "100 Great Inves...ue. , , R&D Directions is a leading pharmaceu...
Other Medicine Technology:Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 2Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 3Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009 2Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009 3Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009 4
34670x Bagolini's Striated Lenses Pair
BD Visitec IOL Manipulator (Fenzl)
BD Visitec IOL Manipulator (Lester)
Maltzman-Fenzl Lens Manipulator
Medicine Products: